West Chester University
117A Schmucker Science
West Chester, PA 19383
Joseph M. Di Bussolo, Ph.D.
Joseph M. Di Bussolo, Ph.D., gave the very first Pharmaceutical Product Development lecture in January of 2002. That lecture on the history of the pharmaceutical industry was soon followed by a lecture on the process of drug discovery and development. Joe gave a third lecture on the role of analytical chemistry in the pharmaceutical industry. As an Adjunct Professor, Dr. Di Bussolo has given updated versions of these PPD lectures each year. Joe has lectured on bio-analytical chemistry and chromatography topics for the chemistry and biology departments of West Chester University of Pennsylvania since 1994.
Joe earned his B.S. degree in clinical chemistry at West Chester University in 1977. In 1982, he received a Ph.D. degree in biological sciences from Drexel University in Philadelphia. Joe spent most of the next 20 years in the development and support of various analytical instruments and software products for the PerkinElmer Corporation. For a few years, he was involved with the development and marketing of chromatography media for the PQ Corporation. In 2002, Joe was appointed by Cohesive Technologies as Director of their Field Applications Laboratory at West Chester University. The laboratory is equipped with advanced chromatographic and spectrometry instrumentation. With the help of WCU chemistry and biology students, Dr. Di Bussolo has developed, presented and published various pharmaceutical and clinical research applications of turbulent-flow liquid chromatography coupled to tandem mass spectrometry (TFLC-MS/MS). In 2006, Cohesive Technologies was acquired by Thermo Fisher Scientific. Joe continues to develop TFLC-MS/MS methods for local pharmaceutical clients such as Merck (West Point, PA), Wyeth (Collegeville, PA), GlaxoSmithKline (Collegeville & Upper Merion, PA) as well as for clinical reference laboratories at the Mayo Clinic (Rochester, MN). In the process, he has mentored and helped many students get jobs at such laboratories.
Marc Duey, M.Sc., M.B.A.
Founder and President of ProMetrics Consulting, Inc., a health care management consulting firm with offices in King of Prussia, PA and Wilmington, NC. Mr. Duey contributes to ProMetrics' market studies practice, which provides pharmaceutical technology assessment, market research, strategic marketing and tactical sales planning. In addition, he designs and implements a range of advanced database services for pharmaceutical and biotechnology firms. Over the last thirteen years, he has managed over 5,000 projects and/or studies for over 100 clients. From 1986 to 1994, he was president of DuWest Research, an international management consulting firm specialized in serving the needs of diagnostic and biotechnology firms from offices in New York, Brussels and Tokyo. Mr. Duey has a Masters of Business Administration (M.B.A.) from the University of Western Ontario, Ivy School of Business, London, Ontario, Canada; and a Masters of Science (M.Sc.) from The University of Ottawa, Department of Biology, Ottawa, Ontario, Canada. Mr. Duey serves on the Board of Directors of several technology-based firms.
James H. Geddes
Mr. Geddes has over 35 years of senior domestic and international management experience in the pharmaceutical/biotechonolgy industry. In his career, Mr. Geddes held senior management positions with SmithKline (now GlaxoSmithKline) where he was responsible for the launch and establishment of "Tagamet", the industry's first $1 billion product. Later, he established and headed the first Managed Care program in the industry growing this concept into a $500 million business in just three years. Mr. Geddes was recruited by Centocor (now a J&J company) to establish staff and manage Marketing, Sales and Customer Service Departments for this new global biotechnology company. He also managed International Operations headquartered in The Netherlands. Subsequently, Mr. Geddes joined Cytogen Corporation, another start-up biotechnology company, where he headed up Strategic Planning, Business Development, Sales and Marketing. Later, Mr. Geddes became President of Barnett International a pharmaceutical/biotechnology focused consulting, education and training company. Under his direction, Barnett International grew from a staff of 15 to 65, and saw revenues grow from $4 million to $35 million. Following his retirement from Barnett International in 2003, Mr. Geddes was recruited to turn around a badly distressed privately owned metal company. As President & CEO of Alliance Metals, Inc., in 3 months Mr. Geddes was able to return the company to profitability and avoid bankruptcy. Mr. Geddes realigned management and operating structure, consolidated operations, inventory and staff and installed needed infrastructure to reposition the company for long-term sustainability. Today, Alliance Metals is a profitable $65 million business with 85 employees in 4 U.S. locations.
Mr. Geddes is an Adjunct Professor at West Chester University of Pennsylvania where he is also a member of the Pharmaceutical Product Development Program Advisory Board as well as the Applied Statistics Graduate Program Advisory Board. Mr. Geddes is also a member of the Board of Directors of St. Joseph's University Pharmaceutical Marketing MBA Program.
Mr. Geddes holds a B.A. in Psychology from the University of Denver, and an M.A. and an Ed.S. in Counseling from the University of Northern Colorado.
Mr. Geddes and his wife Cathy live in Berwyn, PA.